About Boice-Willis Clinic
Clinical Trials at Boice-Willis Clinic
During the past decade, Boice-Willis Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 13 clinical trials were completed, i.e. on
average, 433.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Boice-Willis Clinic" #1 sponsor was "Pfizer" with 4 trials, followed by "Bausch Health Americas, Inc." with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Brigham and Women's Hospital"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Boice-Willis Clinic"
#1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Boice-Willis Clinic
According to Clinical.Site data, the most researched conditions in "Boice-Willis Clinic" are
"Cardiovascular Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Anemia" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Boice-Willis Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Boice-Willis Clinic
Most popular intervention types in "Boice-Willis Clinic" are "Drug" (15 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "5 ASA, enemas, suppositories, corticosteroids" (1 trials), "APF530" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Boice-Willis Clinic
The vast majority of trials in "Boice-Willis Clinic" are
18 trials for "All" genders.
Clinical Trials Status at Boice-Willis Clinic
Currently, there are NaN active trials in "Boice-Willis Clinic".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Boice-Willis Clinic,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Boice-Willis Clinic, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".